Squarepoint Ops LLC Nymox Pharmaceutical Corp Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.22 - $3.39 $26,231 - $40,056	-11,816 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$1.84 - $2.83 $11,590 - $17,826	-6,299 Reduced 34.77%	11,816 $29,000
Q3 2020 Nov 16, 2020	SELL	$2.3 - $3.66 $101,427 - $161,402	-44,099 Reduced 70.88%	18,115 $45,000
Q2 2020 Aug 14, 2020	BUY	$2.1 - $4.6 $130,649 - $286,184	62,214 New	62,214 $221,000
Q1 2018 May 15, 2018	SELL	$3.09 - $4.43 $31,499 - $45,159	-10,194 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.29 - $4.06 $33,538 - $41,387	10,194	10,194 $34,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.